Login / Signup

Evaluation of the Effect of Different Treatment Management on Refractive Outcomes in Severe Retinopathy of Prematurity.

Semra Tiryaki DemirSumeyra Keles YesiltasMurat KarapapakEmine Betul Akbas OzyurekAli BulbulSinan UsluDilek Guven
Published in: Sisli Etfal Hastanesi tip bulteni (2021)
Although spherical power and SEQ can change according to the ROP treatment management, there is no difference in terms of the cylindrical power, prevalence of myopia, and anisometropia. The most important risk factor for myopia and anisometropia in premature children may be ROP severity and retinal immaturity.
Keyphrases
  • young adults
  • type diabetes
  • optic nerve
  • adipose tissue
  • single cell
  • skeletal muscle
  • combination therapy
  • rna seq
  • insulin resistance
  • replacement therapy
  • weight loss
  • glycemic control